Thinking Inside the Box: Endogenous α-Anomeric Lipid Antigens

Jessica Kim, Ji Hyung Kim, Florian Winau

Research output: Contribution to journalShort survey

5 Citations (Scopus)

Abstract

The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal., (2014) demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer. The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal. demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer.

Original languageEnglish
Pages (from-to)505-506
Number of pages2
JournalImmunity
Volume41
Issue number4
DOIs
Publication statusPublished - 2014 Oct 16
Externally publishedYes

Fingerprint

Galactosylceramides
Natural Killer T-Cells
Glycolipids
Porifera
Mammals
Immunity
Lipids
Antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Thinking Inside the Box : Endogenous α-Anomeric Lipid Antigens. / Kim, Jessica; Kim, Ji Hyung; Winau, Florian.

In: Immunity, Vol. 41, No. 4, 16.10.2014, p. 505-506.

Research output: Contribution to journalShort survey

Kim, Jessica ; Kim, Ji Hyung ; Winau, Florian. / Thinking Inside the Box : Endogenous α-Anomeric Lipid Antigens. In: Immunity. 2014 ; Vol. 41, No. 4. pp. 505-506.
@article{5d182712ddfe48aa8a41b9b0faa4c82c,
title = "Thinking Inside the Box: Endogenous α-Anomeric Lipid Antigens",
abstract = "The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal., (2014) demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer. The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal. demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer.",
author = "Jessica Kim and Kim, {Ji Hyung} and Florian Winau",
year = "2014",
month = "10",
day = "16",
doi = "10.1016/j.immuni.2014.09.020",
language = "English",
volume = "41",
pages = "505--506",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Thinking Inside the Box

T2 - Endogenous α-Anomeric Lipid Antigens

AU - Kim, Jessica

AU - Kim, Ji Hyung

AU - Winau, Florian

PY - 2014/10/16

Y1 - 2014/10/16

N2 - The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal., (2014) demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer. The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal. demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer.

AB - The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal., (2014) demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer. The most powerful iNKT cell antigen is α-galactosylceramide (α-GalCer), derived from the marine sponge. However, α-anomeric glycolipids are thought to be absent in mammals. In this issue of Immunity, Kain etal. demonstrate the presence of mammalian α-linked glycosylceramides, such as α-GalCer.

UR - http://www.scopus.com/inward/record.url?scp=84908133236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908133236&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2014.09.020

DO - 10.1016/j.immuni.2014.09.020

M3 - Short survey

C2 - 25367563

AN - SCOPUS:84908133236

VL - 41

SP - 505

EP - 506

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 4

ER -